Akari Therapeutics, Plc (AKTX) /
The debt of Akari Therapeutics, Plc over the past 10 years
Chart Akari Therapeutics, Plc: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Akari Therapeutics, Plc had liquid cash of $5.2M and total debt of $754K: net cash of $4.45M. It had more liquid cash than debt at 8 of the 9 year-ends shown. Total debt was highest at the end of fiscal 2024 ($3.26M) and lowest at the end of fiscal 2016 ($0). No net cash figure is on file for fiscal 2022.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $5.2M | $754K | $4.45M |
| 2024ended Dec 31, 2024 | $2.6M | $3.26M | -$661K |
| 2023ended Dec 31, 2023 | $3.85M | $0 | $3.85M |
| 2022ended Dec 31, 2022 | — | $0 | — |
| 2021ended Dec 31, 2021 | $9.36M | $0 | $9.36M |
| 2020ended Dec 31, 2020 | $14.06M | $0 | $14.06M |
| 2019ended Dec 31, 2019 | $5.73M | $0 | $5.73M |
| 2018ended Dec 31, 2018 | $5.45M | $0 | $5.45M |
| 2017ended Dec 31, 2017 | $28.11M | $0 | $28.11M |
| 2016ended Dec 31, 2016 | $44.12M* | $0 | $44.12M |
Fiscal years as Akari Therapeutics, Plc reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Akari Therapeutics, Plc
- The profitability of Akari Therapeutics, Plc
- The cash flow of Akari Therapeutics, Plc
- All of Akari Therapeutics, Plc's financials, charted
Companies of a similar size
- TSLATesla, Inc.
- LLYELI LILLY AND COMPANY
- AVGOBroadcom Inc.
- MUMicron Technology, Inc.
- METAMeta Platforms, Inc.
Not investment advice. This page shows what Akari Therapeutics, Plc filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.